ArticleBMC pulmonary medicine2026
Microbiome-host interactions in different pathomic subtypes of early-stage lung adenocarcinoma.
Article in BMC pulmonary medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundMicrobiome-host interactions in different pathological subtypes of the early-stage lung adenocarcinoma (LUAD) remain poorly understood.
methodsWe conducted histopathological and imaging analysis on a cohort of 106 Chinese patients with LUAD. Further deep analysis of the lung tissue microbiome, serum metabolome, and host transcriptome was performed. Using correlation analysis, microbial genetic information, and established metabolite-human gene pairs, we integrated multi-omics data to explore potential associations between the microbiome, microbial metabolites, and host gene expression.
findingsWe identified distinct groups based on malignancy severity. Massilia, Sphingomonas, Staphylococcus, and Brevundimonas may influence host gene expression through their metabolites, affecting the progression of LUAD. We used Mendelian Randomization(MR) and found suggestive evidence that the levels of key metabolites (serotonin, uric acid) are negatively associated with LUAD risk. INTERPRETATIONS: This study demonstrates that pathological images of early-stage LUAD cells can reflect potential clinical differences, and some microbial-metabolite-gene potential associations have been found in early-stage LUAD, which may affect the development of early-stage lung adenocarcinoma.
fundingThis research was supported by grants from the National Natural Science Foundation of China (No. 82171931), the Guangdong Basic and Applied Basic Research Foundation Enterprise Joint Fund (2025).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.